Novel, non-toxic ocular antiseptic for intravitreal injection therapy

Ended Project Grant Awarded Last action

Award ID
R44EY031206
Recipient
Awarding agency
Obligated
$6,364,669

Award facts

Assistance listing
93.867 Vision Research
Completion date
Originally
Funding
  • $5,467,648.00 Federal
  • $897,021.00 Non-federal
Place of performance
Palo Alto, CA 94306, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $223,095 $0
Amendment $223,095 $0
Amendment $793,154 $0
Amendment $793,154 $0
Amendment $793,154 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $897,021 $0
Amendment $897,021 $897,021
Original award $847,954 $0
Show all 12

Quick answers

Who received award R44EY031206?

R44EY031206 was awarded to Irenix Medical, Inc. by National Eye Institute (National Institutes of Health) on April 1, 2020.

How much is award R44EY031206 worth?

$6,364,669 has been obligated on R44EY031206: $5,467,648 in federal funding and $897,021 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award